Company
Vaderis Therapeutics AG
Vaderis Therapeutics AG has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Engasertib | Phase 3 | Hereditary Hemorrhagic Telangiectasia |
Latest
No recent events.
Follow Vaderis Therapeutics AG on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.